{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:04:53Z","timestamp":1771002293905,"version":"3.50.1"},"reference-count":38,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2002,1,11]],"date-time":"2002-01-11T00:00:00Z","timestamp":1010707200000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2002,1,7]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Barrett\u2019s oesophagus is associated with an increased risk of the development of oesophageal adenocarcinoma. Endoscopic surveillance every 2\u20135\u2003years has been recommended to prevent death from adenocarcinoma.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim:<\/jats:title><jats:p>To assess the cost\u2010effectiveness of this strategy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>The incremental cost\u2010effectiveness of surveillance (as compared to no surveillance) was analysed with a computer model of a Markov process.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Compared to no surveillance, the incremental cost\u2010effectiveness of bi\u2010annual endoscopy is $16\u2003695 per life\u2010year saved. Surveillance is less cost\u2010effective if the incidence rate of oesophageal adenocarcinoma is low and the 5\u2010year survival rate is high. For surveillance to be cost\u2010effective, there should be little reduction in health\u2010related quality of life following surgical oesophagectomy to prevent death. Moreover, endoscopic surveillance and oesophagectomy need to be efficacious in reliably diagnosing high\u2010grade dysplasia and preventing deaths from cancer. If such ideal conditions of surveillance are not met, the cost per life\u2010year saved could rise five\u2010fold.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>Endoscopic surveillance of patients with Barrett\u2019s oesophagus may be a cost\u2010effective means to prevent death from oesophageal adenocarcinoma.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.2002.01146.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:45:29Z","timestamp":1047354329000},"page":"41-50","source":"Crossref","is-referenced-by-count":62,"title":["Medical decision analysis of endoscopic surveillance of Barrett\u2019s oesophagus to prevent oesophageal adenocarcinoma"],"prefix":"10.1111","volume":"16","author":[{"given":"A.","family":"Sonnenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Soni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. E.","family":"Sampliner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,1,11]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1001\/archinte.1991.00400110070014","article-title":"Barrett\u2019s esophagus: prevalence and incidence of adenocarcinoma","volume":"151","author":"Williamson WA","year":"1991","journal-title":"Arch Intern Med"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01275.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1572-0241.1998.00362.x","article-title":"The Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines of the diagnosis, surveillance and therapy of Barrett\u2019s esophagus","volume":"93","author":"Sampliner RE.","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1052-5157(18)30330-1"},{"key":"e_1_2_6_6_2","first-page":"670","article-title":"A guide for surveillance of patients with Barrett\u2019s esophagus","volume":"89","author":"Provenzale D","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01276.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X9301300409"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.9302"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.18.2331"},{"key":"e_1_2_6_11_2","unstructured":"National Center for Health Statistics. US Decennial Life Tables for 1989\u201391. DHHS Publication No. PHS\u201098\u20101150\u20101 Vol. 1 No. 1. Hyattsville MD: National Center for Health Statistics 1997."},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199102000-00005"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0016-5085(84)90090-8","article-title":"Adenocarcinoma and Barrett\u2019s esophagus: an overrated risk?","volume":"87","author":"Spechler SJ","year":"1984","journal-title":"Gastroenterology"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198510033131404"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800750813"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(89)80011-3"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.30.1.14"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01538065"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.32.12.1441"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.33.9.1155"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1010425"},{"key":"e_1_2_6_22_2","first-page":"212","article-title":"The incidence of adenocarcinoma in Barrett\u2019s esophagus: a prospective study of 170 patients followed for 4\u20138 years","volume":"92","author":"Drewitz DJ","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.33.11.1454"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2388(199707\/08)13:4<245::AID-SSU5>3.0.CO;2-5"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01004.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197703312961304"},{"key":"e_1_2_6_27_2","doi-asserted-by":"crossref","unstructured":"SiegelJE WeinsteinMC TorranceGW.Reporting cost\u2010effectiveness studies and results. In: Gold MR Siegel JE Russel LB Weinstein MC eds. Cost\u2010Effectiveness in Health and Medicine. New York: Oxford University Press 1996: 276\u2013303.","DOI":"10.1093\/oso\/9780195108248.003.0009"},{"key":"e_1_2_6_28_2","unstructured":"DrummondMF O'BrienB StoddartGL TorranceGW. Methods for the Economic Evaluation of Health Care Programmes 2nd edn. New York: Oxford University Press 1997: 96\u2013138 268\u201372."},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90717-X"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X9901900208"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.02173.x"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.39.1.5"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.3.303"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.1995.tb00330.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-8-200010170-00007"},{"key":"e_1_2_6_36_2","first-page":"761","article-title":"Adenocarcinomas of the esophagus and gastric cardia: medical conditions, tobacco, alcohol, and socioeconomic factors","volume":"5","author":"Zhang ZF","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/89.17.1277"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(99)70437-2"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(00)70365-8"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2002.01146.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2002.01146.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2002.01146.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T17:14:11Z","timestamp":1704302051000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2002.01146.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1,7]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1,7]]}},"alternative-id":["10.1046\/j.1365-2036.2002.01146.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2002.01146.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1,7]]}}}